Dabigatran versus Warfarin in Patients with Atrial Fibrillation

被引：0
|
作者：
Worthington, John M. [1 ]
Gattellari, Melina [1 ]
机构：
[1] Univ New S Wales, Sydney, NSW, Australia
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2009年 / 361卷 / 27期
关键词：
D O I：
10.1056/nejmc0909962
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2672 / 2673
页数：2
相关论文
共 50 条
  • [31] EFFECTS OF DABIGATRAN VERSUS WARFARIN IN RELATION TO LEFT VENTRICULAR HYPERTROPHY IN ATRIAL FIBRILLATION
    Verdecchia, Paolo
    Di Pasquale, Giuseppe
    Reboldi, Gianpaolo
    Angeli, Fabio
    Mazzotta, Giovanni
    Brueckmann, Martina
    Kleine, Eva
    Wallentin, Lars
    Ezekowitz, Michael
    Yusuf, Salim
    Connolly, Stuart
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 884 - 884
  • [32] Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation
    Yao, Xiaoxi
    Abraham, Neena S.
    Sangaralingham, Lindsey R.
    Bellolio, M. Fernanda
    McBane, Robert D.
    Shah, Nilay D.
    Noseworthy, Peter A.
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (06):
  • [33] Edoxaban versus Warfarin in Patients with Atrial Fibrillation
    Giugliano, Robert P.
    Ruff, Christian T.
    Braunwald, Eugene
    Murphy, Sabina A.
    Wiviott, Stephen D.
    Halperin, Jonathan L.
    Waldo, Albert L.
    Ezekowitz, Michael D.
    Weitz, Jeffrey I.
    Spinar, Jindrich
    Ruzyllo, Witold
    Ruda, Mikhail
    Koretsune, Yukihiro
    Betcher, Joshua
    Shi, Minggao
    Grip, Laura T.
    Patel, Shirali P.
    Patel, Indravadan
    Hanyok, James J.
    Mercuri, Michele
    Vogelmann, O.
    Gonzalez, C.
    Ahuad Guerrero, R.
    Rodriguez, M.
    Albisu, J.
    Rosales, E.
    Allall, O.
    Reguero, M.
    Alvarez, C.
    Garcia, M.
    Ameriso, S.
    Ameriso, P.
    Amuchastegui, M.
    Caceres, M.
    Beloscar, J.
    Petrucci, J.
    Berli, M.
    Budassi, N.
    Valle, M.
    Bustamante Labarta, G.
    Saravia, M.
    Caccavo, A.
    Fracaro, V.
    Cartasegna, L.
    Novas, V.
    Caruso, O.
    Saa Zarandon, R.
    Colombo, H.
    Morandini, M.
    Cuello, J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (22): : 2093 - 2104
  • [34] Edoxaban versus Warfarin in patients with atrial fibrillation
    Meras Colunga, P.
    [J]. REVISTA CLINICA ESPANOLA, 2014, 214 (06): : 346 - 346
  • [35] Apixaban versus Warfarin in Patients with Atrial Fibrillation
    Granger, Christopher B.
    Alexander, John H.
    McMurray, John J. V.
    Lopes, Renato D.
    Hylek, Elaine M.
    Hanna, Michael
    Al-Khalidi, Hussein R.
    Ansell, Jack
    Atar, Dan
    Avezum, Alvaro
    Cecilia Bahit, M.
    Diaz, Rafael
    Easton, J. Donald
    Ezekowitz, Justin A.
    Flaker, Greg
    Garcia, David
    Geraldes, Margarida
    Gersh, Bernard J.
    Golitsyn, Sergey
    Goto, Shinya
    Hermosillo, Antonio G.
    Hohnloser, Stefan H.
    Horowitz, John
    Mohan, Puneet
    Jansky, Petr
    Lewis, Basil S.
    Luis Lopez-Sendon, Jose
    Pais, Prem
    Parkhomenko, Alexander
    Verheugt, Freek W. A.
    Zhu, Jun
    Wallentin, Lars
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (11): : 981 - 992
  • [36] Safety and effectiveness of dabigatran and warfarin in routine care of patients with atrial fibrillation
    Seeger, John D.
    Bykov, Katsiaryna
    Bartels, Dorothee B.
    Huybrechts, Krista
    Zint, Kristina
    Schneeweiss, Sebastian
    [J]. THROMBOSIS AND HAEMOSTASIS, 2015, 114 (06) : 1277 - 1289
  • [37] Survey of the use of warfarin and the newer anticoagulant dabigatran in patients with atrial fibrillation
    Choi, Jiyoon C.
    DiBonaventura, Marco D.
    Kopenhafer, Lewis
    Nelson, Winnie W.
    [J]. PATIENT PREFERENCE AND ADHERENCE, 2014, 8 : 167 - 177
  • [38] Intracranial Hemorrhage Mortality in Atrial Fibrillation Patients Treated With Dabigatran or Warfarin
    Alonso, Alvaro
    Bengtson, Lindsay G. S.
    MacLehose, Richard F.
    Lutsey, Pamela L.
    Chen, Lin Y.
    Lakshminarayan, Kamakshi
    [J]. STROKE, 2014, 45 (08) : 2286 - 2291
  • [39] Majority of Patients Treated with Warfarin for Atrial Fibrillation are Willing to Switch to Dabigatran
    Elewa, Hazem
    Deremer, Christina
    Keller, Kimble
    Gujral, Jaspal
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2013, 35 (03) : 411 - 411
  • [40] Rivaroxaban versus warfarin or dabigatran in patients undergoing catheter ablation for atrial fibrillation: A meta-analysis
    Phan, Kevin
    Wang, Nelson
    Pison, Laurent
    Kumar, Narendra
    Hitos, Kerry
    Thomas, Stuart P.
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 185 : 209 - 213
12345